✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Mono Pharmacare Ltd.

MONOPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹34 Cr.
P/E
10.86

Mono Pharmacare Ltd.

  • Mono Pharmacare
  • Ushdev International
  • Shrenik

FAQs on Mono Pharmacare Ltd. Shareprice

Mono Pharmacare has given lower returns compared to its competitors.
Mono Pharmacare has grown at ~-48.58% over the last 1yrs while peers have grown at a median rate of -8.04%

Mono Pharmacare is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Mono Pharmacare is 10.86, while 3 year average PE is 19.9.
Also latest EV/EBITDA of Mono Pharmacare is 9.23 while 3yr average is 9.1.

View FAQ's On Business

Growth Table

  • Mono Pharmacare Ltd.
  • Ushdev International
  • Shrenik

Balance Sheet

  • Mono Pharmacare Ltd.
  • Ushdev International
  • Shrenik

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Mono Pharmacare Ltd.
  • Ushdev International
  • Shrenik

Cash Flow

  • Mono Pharmacare Ltd.
  • Ushdev International
  • Shrenik

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Mono Pharmacare Ltd.
  • Ushdev International
  • Shrenik

Quarterly Results

  • Mono Pharmacare Ltd.
  • Ushdev International
  • Shrenik

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Mono Pharmacare Ltd. Financials

Balance sheet of Mono Pharmacare is moderately strong.

Yes, The net debt of Mono Pharmacare is increasing.
Latest net debt of Mono Pharmacare is ₹53.76 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹52.77 Crs.

The profit is oscillating.
The profit of Mono Pharmacare is ₹0.76 Crs for TTM, ₹3.09 Crs for Mar 2025 and ₹2.44 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mono Pharmacare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech